- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04675437
Impact of Exercise Training on Frailty in CVD Patients.
Impact of Aerobic Exercise Training on Markers of Frailty in Heart Failure and CABG Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Frailty is defined as a progressive age-related decline in physiological systems that results in decreased reserves of intrinsic capacity, which confers extreme vulnerability to stressors. Based on previous research, there are indications that frailty is highly prevalent in HF, CABG and mini-AVR patients. As a consequence, these patients (both men and women of 65 years or older) will be included in this research project. The 12-week aerobic exercise program (3 sessions per week) will consist of ergometer, treadmill and arm-ergometer exercises. The intensity will be based on the maximal cardiopulmonary exercise test (CPET) of the patient and will correspond with a heart rate between the first and second ventilatory threshold (with a gradual progression over time).
Secondary, correlations will be examined between markers of the CPET and frailty markers.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Limburg
-
Hasselt, Limburg, Belgium, 3500
- Recruiting
- Jessa Hospital
-
Contact:
- Kim Bonné, Msc
- Phone Number: 003211337701
- Email: kim.bonne@jessazh.be
-
Principal Investigator:
- Nastasia Marinus, Msc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women of at least 65 years of age at the start of the study
- To be admitted to Jessa Hospital Hasselt for cardiac rehabilitation after CABG or mini-AVR surgery or because of HF
- Diagnosed as being frail based on the Phenotype of Fried.
Exclusion Criteria:
- A persistently unstable clinical condition (e.g. angina, advanced conduction disturbances, threatening ventricular arrhythmias or acute HF)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Frail patients (CABG, HF or mini-AVR)
12-weeks cardiac exercise program (3 sessions per week) consisting of aerobic exercises (ergometer, treadmill and arm ergometer).
|
12-weeks aerobic exercise program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in body weight
Time Frame: At baseline (as part of the identification of frailty)
|
To examine whether there was a change in body weight (not due to a diet) in the last year
|
At baseline (as part of the identification of frailty)
|
|
Gait speed
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the gait speed based on the 4.6 metres walking test.
|
At baseline (as part of the identification of frailty)
|
|
Change in gait speed at 12 weeks
Time Frame: 12 weeks
|
To examine the change in gait speed based on the 4.6 metres walking test.
|
12 weeks
|
|
Level of physical activity based on the Katz-scale
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the level of physical activity based on the Katz-scale (which measures the level of (in)dependence in activities of daily living) (score of 0-6 in which a higher score indicates a better level of physical activity)
|
At baseline (as part of the identification of frailty)
|
|
Change in level of physical activity at 12 weeks (0-6) (Higher score = better level of physical activity)
Time Frame: 12 weeks
|
To examine the change in level of physical activity based on the Katz-scale (which measures the level of (in)dependence in activities of daily living) (score of 0-6 in which a higher score indicates a better level of physical activity)
|
12 weeks
|
|
Exhaustion based on 2 questions of the Center of Epidemiologic Studies Depression Scale (CES-D)
Time Frame: At baseline (as part of the identification of frailty)
|
To examine whether the patients suffer from exhaustion based on two questions of the CES-D (in which a score of 2 or 3 on both questions indicates that the patient suffers from exhaustion)
|
At baseline (as part of the identification of frailty)
|
|
Change in level of exhaustion at 12 weeks based on 2 questions of the Center of Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 12 weeks
|
To examine whether there is a change in the level of experienced exhaustion based on two questions of the CES-D (in which a score of 2 or 3 on both questions indicates that the patient suffers from exhaustion)
|
12 weeks
|
|
Handgrip strength
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the handgrip strength measured with the Jamar handheld dynamometer.
|
At baseline (as part of the identification of frailty)
|
|
Change in handgrip strength at 12 weeks
Time Frame: 12 weeks
|
To examine the change in handgrip strength measured with the Jamar handheld dynamometer.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutritional status based on the Mini Nutritional Assessement (MNA)
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the nutritional status based on the MNA (score of 0-30 in which a higher score indicates a better nutritional status)
|
At baseline (as part of the identification of frailty)
|
|
Change in nutritional status at 12 weeks based on the Mini Nutritional Assessement (MNA)
Time Frame: 12 weeks
|
To examine the change in the nutritional status based on the MNA (score of 0-30 in which a higher score indicates a better nutritional status)
|
12 weeks
|
|
Cognitive status based on the Mini Mental State Examination (MMSE)
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the cognitive status based on the MMSE (score of 0-30 in which a higher score indicates a better cognitive status)
|
At baseline (as part of the identification of frailty)
|
|
Change in cognitive status at 12 weeks based on the Mini Mental State Examination (MMSE)
Time Frame: 12 weeks
|
To examine the change in cognitive status based on the MMSE (score of 0-30 in which a higher score indicates a better cognitive status)
|
12 weeks
|
|
Physical status/Comorbidities based on the intake of medications
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the physical status based on the number of medications (in which a higher level of medication intake / higher number of medications indicates a more worse physical status)
|
At baseline (as part of the identification of frailty)
|
|
Change in physical status/Comorbidities at 12 weeks based on the intake of medications
Time Frame: 12 weeks
|
To examine the change in physical status based on the intake of medications (in which a higher level of medication intake / higher number of medications indicates a more worse physical status)
|
12 weeks
|
|
Psychological status based on the Geriatric Depression Scale (GDS-15)
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the psychological status based on the GDS-15 (score of 0-15 in which a higher score indicates a more depressed state)
|
At baseline (as part of the identification of frailty)
|
|
Change in psychological status at 12 weeks based on the Geriatric Depression Scale (GDS-15)
Time Frame: 12 weeks
|
To examine change in the psychological status based on the GDS-15 (score of 0-15 in which a higher score indicates a more depressed state)
|
12 weeks
|
|
Endurance/Balance/Coordination
Time Frame: At baseline (as part of the identification of frailty)
|
To examine the endurance, balance and coordination of the patients based on the Timed up and Go Test
|
At baseline (as part of the identification of frailty)
|
|
Change in endurance/Balance/Coordination at 12 weeks
Time Frame: 12 weeks
|
To examine the change in endurance, balance and coordination of the patients based on the Timed up and Go Test
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FR-AT-CVD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Aerobic exercise
-
Riphah International UniversityCompleted
-
Sultan Abdulhamid Han Training and Research Hospital...RecruitingPhysical InactivityTurkey
-
University of FloridaAmerican Psychological Foundation; Clinical & Translational Science Institute; American Psychological Association (APA)CompletedBrain ConcussionUnited States
-
Radboud University Medical CenterUniversity Hospital, Bonn; University of Dublin, Trinity College; German Sport... and other collaboratorsCompletedMild Cognitive ImpairmentNetherlands, Ireland, Germany
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)TerminatedChildhood ObesityUnited States
-
National Yang Ming UniversityUnknownKnee OsteoarthritisTaiwan
-
National Defense Medical Center, TaiwanMinistry of Science and Technology, TaiwanRecruitingCardiology | PsychiatryTaiwan
-
Bezmialem Vakif UniversityCompletedSpecific Learning DisorderTurkey
-
RenJi HospitalRecruitingST-segment Elevation Myocardial Infarction (STEMI)China
-
Federal University of PelotasMinistry of Health, BrazilUnknownHypertension | Cardiovascular Disease | Chronic Kidney Disease | Chronic Renal DiseaseBrazil